Related Experiment Video
Updated: Jun 14, 2026

Screening for Amyloid Aggregation by Semi-Denaturing Detergent-Agarose Gel Electrophoresis
Published on: July 16, 2008
A Coumarin-Based Array for the Discrimination of Amyloids.
Natalie Trinh1, Kaustubh R Bhuskute2,3, Nikhil R Varghese4
1School of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia.
A novel fluorescent sensor array effectively distinguishes between various disease-associated amyloids, aiding early diagnosis of neurodegenerative diseases like Alzheimer's and Parkinson's. This technology also differentiates disease stages in mouse models.
Area of Science:
- Biochemistry
- Molecular Biology
- Medical Diagnostics
Background:
- Misfolded proteins self-assemble into amyloids, contributing to pathologies like Alzheimer's and Parkinson's diseases.
- Early detection and differentiation of amyloids are critical for diagnosing amyloid-related conditions.
Purpose of the Study:
- To develop a sensitive fluorescent sensor array for discriminating between various disease-associated amyloids.
- To assess the array's capability in distinguishing Alzheimer's disease progression in mouse models.
- To evaluate the array's versatility with functional amyloids.
Main Methods:
- Development of a coumarin-based two-sensor fluorescent array.
- Testing the array's discriminatory power against four distinct disease-associated amyloids.
- Application of the array to samples from Alzheimer's disease mouse models at different disease stages.
- Expansion of analyte testing to include functional amyloids.
Main Results:
- The two-sensor array achieved 100% classification accuracy for four disease-associated amyloids.
- The array successfully discriminated between early and advanced stages of Alzheimer's disease in mouse models.
- The same array demonstrated 100% classification accuracy for a panel of eight disease-associated and functional amyloids.
Conclusions:
- A versatile coumarin-based fluorescent sensor array enables accurate discrimination of multiple amyloids.
- This technology holds promise for the early diagnosis and staging of amyloid-related pathologies, including neurodegenerative diseases.
- The sensor array's flexibility extends its utility to functional amyloids, broadening its diagnostic potential.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
IR and UV–Vis Spectroscopy of Aldehydes and Ketones
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amines to Sulfonamides: The Hinsberg Test
Generally, a primary amine reacts with the Hinsberg reagent to produce an N-substituted benzenesulfonamide. The electron-withdrawing sulfonyl...
Mass Spectrometry of Amines

